Physician profile
Justin Ward
NPI 1336392117
$3,020.94
in general payments reported to CMS, 2019-2025
19 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $295 · 2021: $659 · 2022: $384 · 2023: $590 · 2024: $437 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,301 · Entertainment: $65.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,300.61 |
| Entertainment | $65.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,096.03 | 2019-2025 | Total30, Precision 1, Precision 7 |
| Bausch & Lomb Americas INC. | $426.29 | 2022-2025 | Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $398.61 | 2019-2021 | |
| Optos, INC. | $231.62 | 2020-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $209.86 | 2019-2023 | Acuvue |
| Glaukos Corporation | $138.96 | 2025 | Idosetr |
| Oyster Point Pharma, INC. | $94.17 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Tarsus Pharmaceuticals, INC. | $83.28 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $60.58 | 2021-2022 | |
| Abbvie INC. | $49.87 | 2023 | Vuity, Lumigan, Alphagan P |
| Abb Con-Cise Optical Group LLC | $46.14 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $40.58 | 2020-2021 | |
| Dompe US, INC. | $31.40 | 2025 | Oxervate |
| Allergan, INC. | $24.55 | 2021 | |
| Lkc Technologies, INC. | $23.94 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $19.82 | 2023 | |
| Maculogix, INC. | $16.32 | 2021 | |
| Coopervision INC. | $15.26 | 2019 | |
| Shire North American Group INC | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.